Mazariegos GV et al. |
Weaning of immunosuppression in liver transplant recipients. |
1997 |
Transplantation |
pmid:9020325
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Villalba L and Adams EM |
Update on therapy for refractory dermatomyositis and polymyositis. |
1996 |
Curr Opin Rheumatol |
pmid:9018458
|
Sano Y et al. |
Effect of a single injection of high-dose FK506 on lung transplantation in rats. |
1996 |
Surg. Today |
pmid:9017963
|
Richardson D et al. |
The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome. |
1996 |
Nephrol. Dial. Transplant. |
pmid:9017633
|
Ishizuka T et al. |
Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9016789
|
Noguchi N et al. |
Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsomes. |
1997 |
J. Biol. Chem. |
pmid:9013543
|
DeCenzo MT et al. |
FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. |
1996 |
Protein Eng. |
pmid:9005438
|
Matsui A et al. |
Apparently increased trough levels of tacrolimus caused by acute infantile diarrhea in two infants with biliary atresia after liver transplantation. |
1996 |
Acta Paediatr Jpn |
pmid:9002314
|
Becker G et al. |
Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. |
1997 |
Transpl. Int. |
pmid:9002152
|
Felldin M et al. |
Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis. |
1997 |
Transpl. Int. |
pmid:9002146
|
Pirenne J et al. |
Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. |
1997 |
Surgery |
pmid:9001555
|
Nair SC et al. |
Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. |
1997 |
Mol. Cell. Biol. |
pmid:9001212
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Rambusch EG and Manns MP |
[Therapy of autoimmune hepatitis]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8998922
|
Przepiorka D et al. |
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. |
1996 |
Transplantation |
pmid:8990368
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
|
|
|
|
pmid:8986461
|
Yoshikai Y et al. |
Clonal expansion of superantigen-reactive T cells is resistant to FK506 in mice with AIDS. |
1997 |
J. Virol. |
pmid:8985410
|
High KP and Washburn RG |
Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). |
1997 |
J. Infect. Dis. |
pmid:8985226
|
Sempuku T et al. |
Osteogenic potential of allogeneic rat marrow cells in porous hydroxyapatite ceramics: a histological study. |
1996 |
J. Orthop. Res. |
pmid:8982133
|
Redmon JB et al. |
Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. |
1996 |
J. Clin. Invest. |
pmid:8981925
|
Nichterlein T et al. |
Effects of FK-506 on the course of murine salmonellosis. |
1996 |
J Chemother |
pmid:8981186
|
Odom A et al. |
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. |
1997 |
Antimicrob. Agents Chemother. |
pmid:8980772
|
Blecher O et al. |
A novel plant peptidyl-prolyl-cis-trans-isomerase (PPIase): cDNA cloning, structural analysis, enzymatic activity and expression. |
1996 |
Plant Mol. Biol. |
pmid:8980498
|
James DG |
A new immunosuppressant: tacrolimus. |
1996 |
Postgrad Med J |
pmid:8977938
|
Morris RE |
Transplantation. Beware: shifting paradigms ahead. |
1996 Dec 21-28 |
Lancet |
pmid:8973504
|
Corey HE et al. |
Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy. |
1996 |
Pediatr. Nephrol. |
pmid:8971888
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Hedayat S et al. |
Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants. |
1996 |
J Biopharm Stat |
pmid:8969977
|
Sharkey J et al. |
Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. |
1996 |
Stroke |
pmid:8969794
|
Guérette B et al. |
Increased interferon-gamma mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. |
1996 |
Muscle Nerve |
pmid:8965835
|
Teraoka S et al. |
[Present status and problems in clinical application of tacrolimus(FK506)]. |
1995 |
Nihon Rinsho Meneki Gakkai Kaishi |
pmid:8963787
|
Kawasaki M et al. |
[Immunosuppression and the problems in partial liver transplantation]. |
1995 |
Nihon Rinsho Meneki Gakkai Kaishi |
pmid:8963785
|
Jonas S et al. |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962257
|
Mueller AR et al. |
Long-term follow-up in hepatitis C patients with respect to immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962255
|
Yokoyama I et al. |
Decreased Fas antigen expression of cultured hepatocytes with FK 506. |
1996 |
Transplant. Proc. |
pmid:8962237
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Wilczek HE et al. |
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). |
1996 |
Transplant. Proc. |
pmid:8962232
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Kiuchi T et al. |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. |
1996 |
Transplant. Proc. |
pmid:8962229
|
Becker G et al. |
Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8962228
|
Kliem V et al. |
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. |
1996 |
Transplant. Proc. |
pmid:8962227
|
Scott-Douglas N et al. |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. |
1996 |
Transplant. Proc. |
pmid:8962226
|
Woodle ES et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplant. Proc. |
pmid:8962225
|
Schumacher G et al. |
Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962200
|
Golbaekdal K et al. |
The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs. |
1996 |
J. Pharm. Pharmacol. |
pmid:8961168
|
Antoniou E et al. |
Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival. |
1996 |
Transpl. Int. |
pmid:8959858
|
Fändrich F et al. |
Circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK506) in small bowel transplantation related graft-vs-host disease. |
1996 |
Transpl. Int. |
pmid:8959843
|
Gruessner RW et al. |
Use of FK 506 in pancreas transplantation. |
1996 |
Transpl. Int. |
pmid:8959841
|
Jonas S et al. |
Indications for tacrolimus anti-rejection therapy in liver allograft recipients. |
1996 |
Transpl. Int. |
pmid:8959817
|
Williams R et al. |
Two-year data from the European multicentre tacrolimus (FK506) liver study. |
1996 |
Transpl. Int. |
pmid:8959812
|
Chambraud B et al. |
FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin. |
1996 |
J. Biol. Chem. |
pmid:8955134
|
Ueda S et al. |
In-vitro metabolic studies of tacrolimus using precision-cut rat and human liver slices. |
1996 |
J Pharm Biomed Anal |
pmid:8951695
|
Benelli U et al. |
FK-506 delays corneal graft rejection in a model of corneal xenotransplantation. |
1996 |
J Ocul Pharmacol Ther |
pmid:8951679
|
Iwata M et al. |
Regulation of T cell apoptosis via T cell receptors and steroid receptors. |
1996 |
Stem Cells |
pmid:8948021
|
Brunet M et al. |
Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods. |
1996 |
Ther Drug Monit |
pmid:8946669
|
MacFarlane G et al. |
A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents. |
1996 |
Ther Drug Monit |
pmid:8946668
|
Winkler M et al. |
Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation. |
1996 |
Ther Drug Monit |
pmid:8946659
|
McCall E et al. |
Effects of FK-506 on contraction and Ca2+ transients in rat cardiac myocytes. |
1996 |
Circ. Res. |
pmid:8943949
|
Przepiorka D et al. |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. |
1996 |
Blood |
pmid:8943876
|
Adachi M et al. |
Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain. |
1996 |
Blood |
pmid:8943845
|
Rokaw MD et al. |
Rapamycin inhibits protein kinase C activity and stimulates Na+ transport in A6 cells. |
1996 |
J. Biol. Chem. |
pmid:8943313
|
Poon M et al. |
Rapamycin inhibits vascular smooth muscle cell migration. |
1996 |
J. Clin. Invest. |
pmid:8941644
|
Freiberg RA et al. |
Specific triggering of the Fas signal transduction pathway in normal human keratinocytes. |
1996 |
J. Biol. Chem. |
pmid:8940187
|
Cai W et al. |
Transcription-modulating drugs: mechanism and selectivity. |
1996 |
Curr. Opin. Biotechnol. |
pmid:8939643
|
Ide T et al. |
An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. |
1996 |
Neurosci. Lett. |
pmid:8938254
|
Budde K et al. |
Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation. |
1996 |
Int J Clin Pharmacol Ther |
pmid:8937932
|
Andrews PA et al. |
Racial variation in dosage requirements of tacrolimus. |
1996 |
Lancet |
pmid:8937292
|
Soin AS and Jamieson NV |
Lessons learnt from the multicentre randomized trials of tacrolimus in liver transplantation. |
1996 Sep-Oct |
Natl Med J India |
pmid:8937063
|
Galat A |
A large-scale processing of kinetic data files with derivation of the inhibitory constant Ki: an application to proline isomerases. |
1996 |
Comput. Chem. |
pmid:8936426
|
Bader A et al. |
Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry. |
1996 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8935714
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
Devlin J and Williams R |
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. |
1996 |
Transplantation |
pmid:8932266
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
Shuker SB et al. |
Discovering high-affinity ligands for proteins: SAR by NMR. |
1996 |
Science |
pmid:8929414
|
Yamamoto S et al. |
Cross-species transplantation of photoreceptors with tacrolimus hydrate (FK506) treatment. |
1995 |
Jpn. J. Ophthalmol. |
pmid:8926639
|
Cumming DV et al. |
Pharmacological preconditioning of primary rat cardiac myocytes by FK506. |
1996 Sep-Oct |
Basic Res. Cardiol. |
pmid:8922254
|
Licitra EJ and Liu JO |
A three-hybrid system for detecting small ligand-protein receptor interactions. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8917502
|
Wang X et al. |
Rapamycin inhibits aldolase A expression during human lymphocyte activation. |
1996 |
J. Cell. Biochem. |
pmid:8913875
|
Yagita Y et al. |
Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. |
1996 |
Life Sci. |
pmid:8913329
|
Weigao C |
[Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)]. |
1996 |
Fukuoka Igaku Zasshi |
pmid:8913057
|
Bell A et al. |
The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. |
1996 |
Gen. Pharmacol. |
pmid:8909976
|
Rozen TD et al. |
Treatment-refractory cyclosporine-associated headache: relief with conversion to FK-506. |
1996 |
Neurology |
pmid:8909459
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Alper G and Small SL |
Cerebrospinal fluid after organ transplantation. |
1996 |
Transplant. Proc. |
pmid:8908142
|
Rao AS et al. |
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. |
1996 |
Transplant. Proc. |
pmid:8908140
|
Reyes J et al. |
Intestinal transplantation in children: five-year experience. |
1996 |
Transplant. Proc. |
pmid:8908042
|
Asfar S et al. |
Small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8908039
|
Alessiani M et al. |
Intestinal transplantation with and without the colon in FK 506 immunosuppressed pigs. |
1996 |
Transplant. Proc. |
pmid:8908021
|
Spada M et al. |
Bacterial translocation is enhanced in pig intestinal transplantation when the colon is included in the graft. |
1996 |
Transplant. Proc. |
pmid:8907997
|
Reggiani P et al. |
Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8907965
|
Cicalese L et al. |
Effect of FK506 on the mucosal perfusion of the rat intestinal allograft. |
1996 |
Transplant. Proc. |
pmid:8907959
|
Costa A et al. |
Stimulatory effect of FK506 and erythromycin on pig intestinal motility. |
1996 |
Transplant. Proc. |
pmid:8907957
|